Back

Adaptive data-driven selection of sequences of biological and cognitive markers in clinical diagnosis of dementia

Wyss, P.; Ginsbourger, D.; Shou, H.; Davatzikos, C.; Klöppel, S.; Abdulkadir, A.; ISTAGING Consortium, ; Alzheimer's Disease Neuroimaging Initiative, ; Australian Imaging Biomarkers and Lifestyle flagship study of ageing,

2021-10-26 health informatics
10.1101/2021.10.26.21265515 medRxiv
Show abstract

Effective clinical decision procedures must balance multiple competing objectives such as time-to-decision, acquisition costs, and accuracy. We describe and evaluate POSEIDON, a data-driven method for PrOspective SEquentIal DiagnOsis with Neutral zones to individualize clinical classifications. We evaluated the framework with an application in which the algorithm sequentially proposes to include cognitive, imaging, or molecular markers if a sufficiently more accurate prognosis of clinical decline to manifest Alzheimers disease is expected. The algorithm chose to include optional invasive markers in 37 percent of cases at the cost of 1 percent lower accuracy. Applied to longitudinal data, POSEIDON selected 14 percent of all available measurements and concluded after an average follow-up time of 0.74 years at the expense of five percent lower accuracy. While effective in obtaining timely and economical decisions, our multi-objective evaluation implies that the implementation into consequential clinical applications remains controversial because of the intrinsic dependence on inherently subjective prescribed cost parameters.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.